APOBEC3B and APOBEC3F Inhibit L1 Retrotransposition by a DNA Deamination-independent Mechanism*

The most common transposable genetic element in humans, long interspersed element 1 (L1), constitutes about 20% of the genome. The activity of L1 and related transposons such as Alu elements causes disease and contributes to speciation. Little is known about the cellular mechanisms that control their spread. We show that expression of human APOBEC3B or APOBEC3F decreased the rate of L1 retrotransposition by 5–10-fold. Expression of two related proteins, APOBEC3D or APOBEC3G, had little effect. The mechanism of L1 inhibition did not correlate with an obvious subcellular protein distribution as APOBEC3B appeared predominantly nuclear and APOBEC3F was mostly cytosolic. Two lines of evidence indicated that these APOBEC3 proteins use a deamination-independent mechanism to inhibit L1. First, a catalytically inactive APOBEC3B mutant maintained L1 inhibition activity. Second, cDNA strand-specific C → T hypermutations were not detected among L1 elements that had replicated in the presence of APOBEC3B or APOBEC3F. In addition, lower levels of retrotransposed L1 DNA accumulated in the presence of APOBEC3B and APOBEC3F. Together, these data combined to suggest a model in which APOBEC3B or APOBEC3F provide a preintegration barrier to L1 retrotransposition. A particularly high level of APOBEC3F protein in human testes and an inverse correlation between L1 activity and APOBEC3 gene number suggest the relevance of this mechanism to mammals.

[1]  B. Cullen.  Role and Mechanism of Action of the APOBEC3 Family of Antiretroviral Resistance Factors , 2006, Journal of Virology.

[2]  S. Calattini,et al.  Restriction of Foamy Viruses by APOBEC Cytidine Deaminases , 2006, Journal of Virology.

[3]  B. Cullen,et al.  APOBEC3A and APOBEC3B are potent inhibitors of LTR-retrotransposon function in human cells , 2006, Nucleic acids research.

[4]  Stéphane Boissinot,et al.  Molecular evolution and tempo of amplification of human LINE-1 retrotransposons since the origin of primates. , 2005, Genome research.

[5]  Erik K. Malm,et al.  A Human Protein Atlas for Normal and Cancer Tissues Based on Antibody Proteomics* , 2005, Molecular & Cellular Proteomics.

[6]  M. Malim,et al.  APOBEC‐mediated interference with hepadnavirus production , 2005, Hepatology.

[7]  D. Nissley,et al.  APOBEC3G hypermutates genomic DNA and inhibits Ty1 retrotransposition in yeast. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[8]  B. Cullen,et al.  Foamy Virus Bet Proteins Function as Novel Inhibitors of the APOBEC3 Family of Innate Antiretroviral Defense Factors , 2005, Journal of Virology.

[9]  S. Wain-Hobson,et al.  Extensive editing of both hepatitis B virus DNA strands by APOBEC3 cytidine deaminases in vitro and in vivo. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[10]  Amane Sasada,et al.  APOBEC3G targets human T-cell leukemia virus type 1 , 2005, Retrovirology.

[11]  B. Cullen,et al.  Inhibition of a Yeast LTR Retrotransposon by Human APOBEC3 Cytidine Deaminases , 2005, Current Biology.

[12]  M. Liddament,et al.  The Retroviral Hypermutation Specificity of APOBEC3F and APOBEC3G Is Governed by the C-terminal DNA Cytosine Deaminase Domain* , 2005, Journal of Biological Chemistry.

[13]  R. König,et al.  Complementary function of the two catalytic domains of APOBEC3G. , 2005, Virology.

[14]  T. Heidmann,et al.  APOBEC3G cytidine deaminase inhibits retrotransposition of endogenous retroviruses , 2005, Nature.

[15]  M. Malim,et al.  Antiviral Function of APOBEC3G Can Be Dissociated from Cytidine Deaminase Activity , 2005, Current Biology.

[16]  R. König,et al.  APOBEC3B and APOBEC3C Are Potent Inhibitors of Simian Immunodeficiency Virus Replication* , 2004, Journal of Biological Chemistry.

[17]  J. Seppen.  Unedited inhibition of HBV replication by APOBEC3G. , 2004, Journal of hepatology.

[18]  D. Trono,et al.  The Innate Antiretroviral Factor APOBEC3G Does Not Affect Human LINE-1 Retrotransposition in a Cell Culture Assay* , 2004, Journal of Biological Chemistry.

[19]  M. Malim,et al.  Cytidine Deamination of Retroviral DNA by Diverse APOBEC Proteins , 2004, Current Biology.

[20]  W. Brown,et al.  APOBEC3F Properties and Hypermutation Preferences Indicate Activity against HIV-1 In Vivo , 2004, Current Biology.

[21]  M. Emerman,et al.  Ancient Adaptive Evolution of the Primate Antiviral DNA-Editing Enzyme APOBEC3G , 2004, PLoS biology.

[22]  B. Cullen,et al.  A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV‐1 and HIV‐2 Vif proteins , 2004, The EMBO journal.

[23]  J. V. Moran,et al.  Mobile elements and mammalian genome evolution. , 2003, Current opinion in genetics & development.

[24]  A. Takaori-Kondo,et al.  The Enzymatic Activity of CEM15/Apobec-3G Is Essential for the Regulation of the Infectivity of HIV-1 Virion but Not a Sole Determinant of Its Antiviral Activity* , 2003, Journal of Biological Chemistry.

[25]  M. Marin,et al.  HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation , 2003, Nature Medicine.

[26]  Hui Zhang,et al.  The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA , 2003, Nature.

[27]  Gersende Caron,et al.  Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts , 2003, Nature.

[28]  J. V. Moran,et al.  Hot L1s account for the bulk of retrotransposition in the human population , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[29]  Reuben S Harris,et al.  RNA editing enzyme APOBEC1 and some of its homologs can act as DNA mutators. , 2002, Molecular cell.

[30]  M. Malim,et al.  Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein , 2002, Nature.

[31]  E. Ostertag,et al.  Biology of mammalian L1 retrotransposons. , 2001, Annual review of genetics.

[32]  J. V. Moran,et al.  Initial sequencing and analysis of the human genome. , 2001, Nature.

[33]  J. V. Moran,et al.  Determination of L1 retrotransposition kinetics in cultured cells. , 2000, Nucleic acids research.

[34]  Jef D Boeke,et al.  High Frequency Retrotransposition in Cultured Mammalian Cells , 1996, Cell.

[35]  S. Martin,et al.  Developmental and cell type specificity of LINE-1 expression in mouse testis: implications for transposition , 1994, Molecular and cellular biology.